Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.

Han SL, Wan SL.

Int J Clin Pract. 2012 Feb;66(2):199-209. doi: 10.1111/j.1742-1241.2011.02837.x. Review.

PMID:
22257045
2.
3.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
4.

Reduced risk of back pain following teriparatide treatment: a meta-analysis.

Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH.

Osteoporos Int. 2006 Feb;17(2):273-80. Epub 2005 Sep 2. Review.

PMID:
16142502
5.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
6.

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G.

Cochrane Database Syst Rev. 2003;(4):CD004523. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.

PMID:
14584020
7.

Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.

Vestergaard P, Jorgensen NR, Mosekilde L, Schwarz P.

Osteoporos Int. 2007 Jan;18(1):45-57. Epub 2006 Sep 2. Review.

PMID:
16951908
8.
9.

Teriparatide: A bone formation treatment for osteoporosis.

Eriksen EF, Robins DA.

Drugs Today (Barc). 2004 Nov;40(11):935-48. Review.

PMID:
15645006
10.

Osteoporosis: trials and tribulations.

Seeman E.

Am J Med. 1997 Aug 18;103(2A):74S-87S; discussion 87S-89S. Review.

PMID:
9302899
11.

Preventing osteoporosis-related fractures: an overview.

Gass M, Dawson-Hughes B.

Am J Med. 2006 Apr;119(4 Suppl 1):S3-S11. Review.

PMID:
16563939
12.

[Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].

Sowa H, Hamaya E, Yamamoto T.

Clin Calcium. 2011 Jan;21(1):9-16. doi: CliCa1101916. Review. Japanese.

PMID:
21187589
13.

Anabolic skeletal therapy for osteoporosis.

Girotra M, Rubin MR, Bilezikian JP.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):745-54. Review.

14.

A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.

Chen JF, Yang KH, Zhang ZL, Chang HC, Chen Y, Sowa H, Gürbüz S.

Osteoporos Int. 2015 Jan;26(1):11-28. doi: 10.1007/s00198-014-2838-7. Epub 2014 Aug 20. Review.

PMID:
25138261
15.

Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.

Cortet B.

Rheumatology (Oxford). 2009 Oct;48 Suppl 4:iv14-9. doi: 10.1093/rheumatology/kep275. Review.

16.

WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004526. Review.

PMID:
17636765
17.

Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2004;(1):CD004526. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004526.

PMID:
14974070
18.

Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2003;(4):CD004526. Review. Update in: Cochrane Database Syst Rev. 2004;(1):CD004526.

PMID:
14584022
19.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Conwell LS, Chang AB.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002010. doi: 10.1002/14651858.CD002010.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD002010.

PMID:
19821288
20.

Vitamin K to prevent fractures in older women: systematic review and economic evaluation.

Stevenson M, Lloyd-Jones M, Papaioannou D.

Health Technol Assess. 2009 Sep;13(45):iii-xi, 1-134. doi: 10.3310/hta13450. Review.

Items per page

Supplemental Content

Write to the Help Desk